What test identifies hyperadrenergic postural orthostatic tachycardia syndrome (POTS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosing Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS)

The most definitive test to identify hyperadrenergic POTS is measuring serum norepinephrine levels upon standing, with a level ≥600 pg/mL confirming the diagnosis, along with an increase in systolic blood pressure of ≥10 mmHg during standing or head-up tilt testing. 1

Diagnostic Criteria for Hyperadrenergic POTS

  • Hyperadrenergic POTS is diagnosed when a patient meets general POTS criteria (heart rate increase ≥30 bpm or exceeding 120 bpm within 10 minutes of standing) PLUS demonstrates hyperadrenergic features 2
  • The key diagnostic markers of hyperadrenergic POTS are:
    • Serum norepinephrine level ≥600 pg/mL upon standing 1
    • AND/OR an increase in systolic blood pressure ≥10 mmHg during head-up tilt test or standing 1
  • The diagnosis requires the absence of orthostatic hypotension (defined as systolic BP drop ≥20 mmHg or diastolic BP drop ≥10 mmHg within 3 minutes of standing) 2, 3

Testing Protocol

  • Perform a 10-minute active stand test with continuous monitoring of vital signs 3
    • Measure blood pressure and heart rate after 5 minutes of lying supine
    • Record measurements immediately upon standing, and at 2,5, and 10 minutes after standing
    • Patient must stand quietly for the full 10 minutes as heart rate increase may take time to develop
  • Draw blood for catecholamine levels (specifically norepinephrine) while the patient is standing 1, 4
  • Head-up tilt table testing can be used as an alternative to active standing test, particularly if the active stand test is inconclusive 2, 3

Clinical Features Suggesting Hyperadrenergic POTS

  • Patients with hyperadrenergic POTS typically present with more pronounced symptoms compared to other POTS subtypes 4:
    • More frequent dizziness and headaches 4
    • Tremulousness or tremor 4
    • Palpitations and anxiety 3, 5
    • Greater increases in both heart rate and systolic blood pressure during orthostatic testing 4
  • These patients often have symptoms suggestive of sympathetic overactivation 5:
    • Excessive sweating
    • Cold or clammy extremities
    • Pupillary dilation

Important Testing Considerations

  • Testing should be performed in a quiet environment with temperature controlled between 21-23°C 3
  • Patients should be fasted for 3 hours before the test 3
  • Avoid nicotine, caffeine, theine, or taurine-containing drinks on the day of examination 3
  • Tests should ideally be performed before noon 3
  • Medications that might affect autonomic function should be discontinued before testing when possible 3

Common Pitfalls in Diagnosis

  • Failure to perform the active stand test for the full 10 minutes may miss delayed heart rate increases 3
  • Not distinguishing hyperadrenergic POTS from neuropathic POTS can lead to suboptimal treatment approaches 1, 5
  • Failing to measure serum norepinephrine levels while standing can miss the diagnosis 1, 4
  • Not considering the hyperadrenergic subtype when standard POTS treatments fail 1
  • Confusing hyperadrenergic POTS with anxiety disorders due to overlapping symptoms 5

Treatment Implications

  • Identifying hyperadrenergic POTS is clinically important as these patients often respond differently to standard POTS treatments 1
  • Patients with hyperadrenergic POTS may benefit from specific treatments targeting the hyperadrenergic state, such as ivabradine 6
  • These patients are often more difficult to treat and may require multiple medication combinations 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosing Postural Orthostatic Tachycardia Syndrome (POTS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical features of hyperadrenergic postural tachycardia syndrome in children.

Pediatrics international : official journal of the Japan Pediatric Society, 2014

Research

Postural tachycardia syndrome - Diagnosis, physiology, and prognosis.

Autonomic neuroscience : basic & clinical, 2018

Related Questions

What is the protocol for performing a standing test to diagnose Postural Orthostatic Tachycardia Syndrome (POTS)?
What is the cause of intermittent lightheadedness in a patient with a history of spina bifida, recent travel, and no orthostatic hypotension?
What is the best management approach for a 48-year-old female with Hyperlipidemia (HLD), Type 2 Diabetes Mellitus (DM 2), fibromyalgia, and a current smoker, presenting with Postural Orthostatic Tachycardia Syndrome (POTS) symptoms, borderline concentric left ventricular hypertrophy (LVH), and a left ventricular ejection fraction (LVEF) of 45-50%?
What is the best course of treatment for a female patient with a history of hyperlipidemia (HLD), type 2 diabetes mellitus (DM 2), fibromyalgia, and a current smoker, presenting with symptoms of postural orthostatic tachycardia syndrome (POTS), including lightheadedness and dizziness upon standing, with a diagnosis of heart failure with reduced ejection fraction?
What is the approach to testing and treating a 23-year-old female patient presenting with concerns for Postural Orthostatic Tachycardia Syndrome (POTS)?
What is the recommended treatment regimen for tuberculosis based on drug susceptibility test results?
What is the most likely cause of a false-positive fecal occult blood test (FOBT)?
Can platelet concentrate be administered as a fast drip?
What beta-lactam (β-lactam) antibiotics are effective against Pseudomonas aeruginosa?
Should HIV testing be performed on all patients suspected of having Tuberculosis (TB)?
What is the evaluation and management approach for peripheral nerve sheath tumors (PNSTs)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.